Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Nasal Spray and Varenicline in Methadone-Maintained Smokers
NCT02147132Phase 4Terminated
- Sponsor
- University of Cincinnati
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine patch, varenicline + nicotine patch in Tobacco Use Disorder (TUD), sponsored by University of Cincinnati. Started Mar 2016; status: terminated.
02
Drugs
nicotine patchvarenicline + nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02147132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147132.